Abstract
As demonstrated by these results, there is a large area of need, largely unmet [1]. Survivorship care programmes are in general, lacking. Psychosexual care and medical care, quality of life [2] and patient self-efficacy [3] are the main areas of development in a structured survivorship pathway. Without this, increased primary health care use results [4]. Communication and discussion of physical symptoms are central to a survivorship pathway [5, 6]. Healthcare input is an important factor associated with successful survivorship care, covering side effects and therapy and medical health.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63.
Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamiton RJ, Trachtenberg J, Zlotta AR, Toi A, Evans A, Van Der Kwast TH, Fleshner NE. Prostate biopsy trends in relation to U.S. Preventative Task for recommendations against routine PSA-based screening: a time-series analysis. Eur Urol Suppl. 2014;13(1):e852.
Meade CD, Calvo A, Rivera MA, Baer RD. Focus groups in the design of prostate cancer screening information for Hispanic farmworkers and African American men. Oncol Nurs Forum. 2003;30:967–75.
Megas G, Papadopoulos G, Stathouros G, Moschonas D, Gkialas I, Ntoumas K. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor Tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction. BJU Int. 2013;112:E169–76.
Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772–80.
Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin PW, Sanda MG. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology. 2006;68:166–71.
Miner MM. Erectile dysfunction: a harbinger for cardiovascular events and other comorbidities, thereby allowing a ‘window of curability’. Int J Clin Pract. 2009;63:1123–6.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Online). 2009;339:332–6.
Molton IR, Siegel SD, Penedo FJ, Dahn JR, Kinsinger D, Traeger LN, Carver CS, Shen BJ, Kumar M, Schneiderman N, Antoni MH. Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity. J Psychosom Res. 2008;64:527–36.
Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, Demark-Wahnefried W. Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer. 2009;115:4001–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Goonewardene, S.S., Persad, R. (2018). Systematic Review Findings on Prostate Cancer Survivorship. In: Prostate Cancer Survivorship . Springer, Cham. https://doi.org/10.1007/978-3-319-65358-7_99
Download citation
DOI: https://doi.org/10.1007/978-3-319-65358-7_99
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65357-0
Online ISBN: 978-3-319-65358-7
eBook Packages: MedicineMedicine (R0)